Delivery in a patient with induced pregnancy in an assisted reproductive technology (surrogacy) program and with placenta increta
Background. Placenta increta is a relevant problem of contemporary obstetrics. Over the past decade, the rate of this abnormality has increased by 50 times. The importance of the problem is increasing due to massive bleeding, in which the maternal mortality rate is as much as 7%. Placenta increta is one of the most severe abnormalities resulting from the partial or complete absence of the spongy layer of the decidua due to endometrial atrophic processes.Shaklein A.V., Drobinskaya A.N., Delsuz S.F., Davydov I.M., Pasman N.M., Stepanova A.A., Kolesnikova A.V., Bystrova E.V.
Case report. The article describes a clinical case of a patient with pregnancy induced by an assisted reproductive technology (surrogacy) program and placenta increta. It describes in detail the mechanisms of pathogenesis, as well as delivery methods for abnormal placental invasion.
Conclusion. The given clinical case is a demonstration of successfully applying a team approach during delivery in a woman with placenta increta: the introduction of current diagnostic and therapeutic blood-saving technologies and a surgical delivery method that does not require an additional uterine incision.
Keywords
placenta increta
endometrial dystrophic changes
cesarean section
endovascular balloon occlusion of the common iliac arteries
References
- Ran Cui, Menghui Li, Junli Lu, Huimin Bai, Zhenyu Zhang. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study. BMC Pregnancy Childbirth. 2018; 18(1): 298. https://dx.doi.org/10.1186/s12884-018-1935-6.
- Thurn L., Lindqvist P.G., Jakobsson M., Colmorn L.B., Klungsoyr K., Bjarnadóttir R.I. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: Results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2015; 123(8): 1348-55. https://dx.doi.org/10.1111/1471-0528.13547.
- Silver R.M. Abnormal placentation: Placenta previa, vasa previa, and placenta accrete. Obstet. Gynecol. 2015; 126(3): 654-68. https://dx.doi.org/10.1097/AOG.0000000000001005.
- Shmakov R.G., Vinitskiy A.A., Chuprinin V.D., Yarotskaya E.L., Sukhikh G.T. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery. J. Matern. Fetal Neonatal Med. 2019; 32(12): 2042-8. https://dx.doi.org/10.1080/14767058.2018.1424821.
- Kaser D.J., Melamed A., Bormann C.L., Myers D.E., Missmer S.A., Walsh B.W. et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil. Steril. 2015; 103(5): 1176-84. https://dx.doi.org/ 10.1016/j.fertnstert.2015.01.021.
- Jauniaux E., Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012; 33(4): 244-51. https://dx.doi.org/10.1016/j.placenta.2011.11.010.
- Jauniaux E., Bhide A., Burton G.J. Pathophysiology of accreta. In: Silver R., ed. Placenta accrete syndrome. Portland: CRC Press. 2017: 13-28.
- Королев А.Ю., Пырегов А.В., Федорова Т.А., Шмаков Р.Г., Герасимов Ю.А., Шпилюк М.А., Медведева А.А. Безопасность регионарной анестезии при родоразрешении беременных с врастанием плаценты. Акушерство и гинекология. 2019; 1: 92-7. [Korolev A.Yu., Pyregov A.V., Fedorova T.A., Shmakov R.G., Gerasimov Yu.A., Shpilyuk M.A. et al. Safety of regional anesthesia during delivery in pregnant women with placenta increta. Akusherstvo i Ginekologiya (Obstetrics and Gynecology). 2019; 1: 92–7. (in Russian)].
- Шмаков Р.Г., Чупрынин В.Д., Кан Н.Е., Тютюнник В.Л., Виницкий А.А. Способ временной окклюзии общих подвздошных артерий при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RUS 2625286 26.09.2016. [Shmakov R.G., Chuprynin V.D., Kan N.E., Tyutyunnik V.L., Vinitsky A.A. A method for temporary occlusion of the common iliac arteries during organ-sparing surgical delivery in patients with placenta increata. RUS Patent for invention 2625286 dated September 26, 2016. (in Russian)].
- Шмаков Р.Г., Чупрынин В.Д., Виницкий А.А. Способ двухуровнего гемостаза при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RUS 2626984 05.10.2016. [Shmakov R.G., Chuprynin V.D., Vinitsky A.A. A method for two-level hemostasis during organ-sparing surgical delivery in patients with placenta increata. RUS Patent for invention 2626984 dated May 10, 2016. (in Russian)].
- Шмаков Р.Г., Чупрынин В.Д., Виницкий А.А. Комплексный компрессионный гемостаз при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RUS 2627633 13.12.2016. [Shmakov R.G., Chuprynin V.D., Vinitsky A.A. Comprehensive compression hemostasis during organ-sparing surgical delivery in patients with placenta increata. RUS Patent for invention 2627633 dated December 13, 2016. (in Russian)].
Received 29.11.2019
Accepted 07.02.2020
About the Authors
Aleksandr V. Shaklein, MD, Head of the Obstetric and Gynecological Service of Maternity Hospital №1. Теl.: +7(913)921-54-02. E-mail: a_shaklein@mail.ru.1 Zalesskogo Str., Novosibirsk, 630047, Russian Federation.
Alla N. Drobinskaya, PhD, Chief external resuscitator MOH NSO for childbirth, Head doctor of the Central City Hospital NSO Berdsk, Associate professor of the Department of Anesthesiology and Intensive Care NNRSU. Tel.: +7(913)377-77-27. E-mail: drobinskayaa@mail.ru.
2 Pirogova Str., Novosibirsk, 630090, Russian Federation.
Sofya F. Delsuz, Medical Resident, NNRSU. Tel.: +7(964)0956975. E-mail: delya_djal-side@mail.ru; 2 Pirogova Str., Novosibirsk, 630090, Russian Federation.
Ilya M. Davydov, Head of Anesthesiology and Intensive Care №1 of Maternity Hospital MCH №1, anesthesiologist-resuscitator of the highest qualification category.
Tel.: +7(913)9138610. E-mail: newlife_nsk@mail.ru. 1 Zalesskogo Str., Novosibirsk, 630047, Russian Federation.
Natalya M. Pasman, MD, PhD, Professor, Obstetrician-gynecologist, Head of the Department of Obstetrics and Gynecology, NNRSU; Director of «Professor Pasman clinic» LLC. Tel.: +7(913)916-25-91. E-mail: nmpasman@gmail.com. 2 Pirogova Str., Novosibirsk, 630090, Russian Federation.
Anastasia A. Stepanova, PhD, Head of the Department of Obstetrics Pathology of Pregnant of Maternity Hospital MCH №1, obstetrician-gynecologist of the highest qualification category. Теl.: +7 (913)906-73-67. E-mail: Ste3550@yandex.ru. 1 Zalesskogo Str., Novosibirsk, 630047, Russian Federation.
Aleksandra V. Kolesnikova, obstetrician-gynecologist of Maternity Hospital MCH №1. Теl.: +7 (913)709-16-60.
E-mail: sasha_kol@mail.ru. 1 Zalesskogo Str., Novosibirsk, 630047, Russian Federation.
Evgeniya V. Bystrova, Head of the Postpartum Department, obstetrician-gynecologist of the Maternity Hospital MCH №1. ,
Tel.: +7(913)018-44-97. E-mail: bystrova.e.v@mail.ru. 1 Zalesskogo Str., Novosibirsk, 630047, Russian Federation.
For reference: Shaklein A.V., Drobinskaya A.N., Delsuz S.F., Davydov I.M., Pasman N.M., Stepanova A.A., Kolesnikova A.V., Bystrova E.V. Delivery in a patient with induced pregnancy in an assisted reproductive technology (surrogacy) program and with placenta increta.
Akusherstvo i Ginekologiya/ Obstetrics and Gynecology. 2020; 5: 181-85 (In Russian).
https://dx.doi.org/10.18565/aig.2020.5.181-85
Similar Articles
